JPRN-UMIN000023543招募中未知
Exploratory study of WT-1 pulsed dendritic cell immunotherapy as a 2nd line treatment for patients with advanced/recurrent thymic carcinoma. - Phase II study of WT-1 pulsed dendritic cell immunotherapy for patients with thymic carcinoma.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with active concomitant malignancy 2) Patients have allergy for OK-432 or penicillin 3) With uncontrollable hypertension or diabetes 4) With angina pectoris or myocardial infarction 5) With uncontrollable heart failure or cerebrovascular disorder 6) With pulmonary fibrosis or interstitial pneumonia 7) With bleeding ulcer, intestinal obstruction 8) With Immunosuppressive agent or predonine 9) With severe allergy disease 10) With autoimmune disease 11) With myelodysplastic syndrome 12) Pregnancy or lactation. 13) Patients with mental disorder, and considered as inappropriate for the study by the physicians 14) Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
已完成
1 期
Phase I/II study of peptide pulsed dendritic cell vaccination combined with carboplatin and paclitaxel for patients with advanced malignant melanomaunresectable malignant melanomaJPRN-UMIN000006629Keio University, School of Medicine10
招募中
1 期
WT1 peptide-pulsed dendritic cell therapy for wet age-related macular degeneratiowet age-related macular degenerationJPRN-jRCTc030210068Gunji Hisato10
尚未招募
不适用
A phase I study on Dendritic cells loaded with allogeneous cell lysate (Alloys) in patients with mesothelioma as maintenance treatment (AlloDen)asbestos cancermesothelioma10027412NL-OMON41650Erasmus MC, Universitair Medisch Centrum Rotterdam18
招募中
不适用
Phase I, Open-Label Study With Dendritic Cell therapy (MesoPher) In Combination With Ex-tended-Pleurectomy/Decortication After Chemotherapy in Subjects With Resectable Mesothelioma.malignant pleural mesotheliomaNL-OMON52279Erasmus MC, Universitair Medisch Centrum Rotterdam16
进行中（未招募）
1 期
DC for endometrial cancer patientsmetastatic endometrial cancerEUCTR2018-004467-31-NL8